Objectives Acute mesenteric ischemia is an infrequent cause of abdominal pain in
emergency department (ED) patients; however, mortality for this condition is high. Rapid …

Ischemia modified albumin (IMA), as measured using the albumin cobalt binding test, is
currently the most promising biomarker for early detection of ischemia before the onset of …

Acute intestinal ischemia is a relative rare abdominal emergency, associated with
considerably high morbidity and mortality rates. Although the conventional diagnostic …

Purpose Due to the diagnostic challenges and dreadful consequences of delayed treatment
of acute mesenteric ischemia (AMI), a variety of diagnostic markers have been previously …

Context: Metabolic syndrome (MS) is described as a cluster of cardiometabolic risk factors.
Studies suggest that ischemia-modified albumin (IMA) is a biomarker of cardiovascular …

Objective To clarify the presence of oxidative stress in patients with primary angle-closure
glaucoma (PACG) and to investigate the relationship between oxidative stress and PACG …

Objectives This study investigated the diagnostic value of signal peptide‐CUB‐EGF domain‐
containing protein 1 (SCUBE‐1) and other oxidative stress parameters in the early diagnosis …

Objective There is an urgent need for accurate biomarkers to support timely diagnosis of
acute mesenteric ischaemia (AMI) and thereby improve clinical outcomes. With this …

Purpose: To establish the correlation between ischemia-modified albumin (IMA) and
malondialdehyde (MDA) and the development of diabetic retinopathy (DRP) in patients with …

Objectives: This experimental study aimed to assess the changes in the levels of serum
ischemia‐modified albumin (IMA) and interleukin‐6 (IL‐6) by time in cases of acute …